Weekly Rundown: Key Catalysts for Small-Cap Stocks (July 28 – August 1)

We’ve tracked the latest disclosures and corporate developments to highlight this week’s most impactful small-cap catalysts. Below is our weekly preview for July 28 – August 1.

Companies Presenting at the 2025 Alzheimer's Association International Conference (AAIC)

July 27–31, 2025 | Toronto, Canada
● IGC - Showcasing innovations in AI-driven drug discovery and early disease detection, including solutions for low-resource settings and the Multimodal Interpretable Transformer for Alzheimer’s Disease (MINT-AD). Presentations include MINT-AD: Early Prediction of MMSE & CSI-D Scores with AI and AI applications in the drug discovery pipeline.

● ANVS - Presenting four scientific posters highlighting advances in its Alzheimer’s clinical program and the pharmacokinetic characterization of its lead drug candidate, buntanetap.

● ABOS - Presenting how combining biomarker-driven screening with a targeted therapeutic such as sabirnetug represents meaningful progress in clinical trial design and drug development for Alzheimer’s disease.

● INMB - Releasing additional analyses from the Phase 2 MINDFuL trial evaluating XPro™, a novel selective soluble TNF inhibitor, in an oral presentation.

● CGTX - James E. Galvin, MD, MPH, will present results from the Phase 2 ‘SHIMMER’ study of zervimesine (CT1812) in dementia with Lewy bodies (DLB) during an oral presentation on July 29, 2025. Dr. Galvin is the director of the Comprehensive Center for Brain Health at the University of Miami Miller School of Medicine and served as study director for COG1201 SHIMMER (NCT05225415).

Companies Participating in the BTIG Virtual Biotechnology Conference

July 29–30, 2025

● IMAB ● CNTB ● WHWK ● VTGN ● OVID ● VERU ● GANX ● MDCX

Other Companies with Key Catalysts This Week:

SYTA - Announced a strategic partnership with RAM® Mounts to deliver advanced in-vehicle mounting solutions for Siyata's SD7, SD7 ULTRA, and future handsets. The integrated products will debut at APCO 2025 (July 27–30, Baltimore Convention Center).

INBS - Presenting pharmacokinetic (PK) study results at the ADLM 2025 Clinical Lab Expo (July 27–31, Chicago, IL).

ELAB - Participating in the 2025 ITAD Summit (Booth A07) on July 29–30 at The Bellagio, Las Vegas, marking its first presence at the event.

OTLK - Presenting at the 8th Annual OIS Retina Innovation Summit on July 29.

CRDF - Hosting a conference call on July 29 at 4:30 p.m. ET to discuss additional clinical data from its randomized Phase 2 trial (CRDF-004) evaluating onvansertib in combination with standard-of-care treatment for first-line RAS-mutated metastatic colorectal cancer.

GAME - Holding a livestream on July 29 at 12:00 p.m. ET with top leaders in decentralized finance to discuss its $250M Ethereum treasury strategy targeting 8–14% onchain yields. Featured speakers include GameSquare CEO Justin Kenna, Ryan Zurrer (Dialectic AG), Robert Leshner (Superstate), and Rhydon Lee (Goff Capital).

TRUG - Officially opening its first TruGolf Links franchise on July 29 at 450 S Spruce Street in Manteno, Illinois. The grand opening celebration runs from 10 a.m. to 2 p.m., with remarks by Chief Development Officer Dr. Ben Litalien and Manteno Mayor Annette LaMore beginning at noon.

SSY - Holding a Special Meeting of Stockholders on July 29 at 10:00 a.m. EDT to vote on its proposed merger with Regional Health Properties, Inc. under the Amended and Restated Agreement and Plan of Merger dated April 14, 2025.

● A Special Cash Dividend of $0.10 per share will be paid to shareholders of record as of July 29.

● Due bill trading applies: investors must hold shares through July 30 (the payment date) to receive the dividend.

SURG - CEO Brian Cox will appear in a live fireside chat hosted by John Roy of Water Tower Research on July 29, discussing SurgePays’ position in wireless, fintech, and point-of-sale technologies.

FDMT - Delivering podium presentations at the 43rd Annual ASRS Scientific Meeting (July 30–August 2, Long Beach, CA).

ANNX - Dr. David Eichenbaum will present the design and rationale of the pivotal Phase 3 ARCHER II trial at ASRS 2025 on July 31.

LWLG - CEO Yves LeMaitre to host a corporate update call on July 31.

XTIA - Hosting an investor webinar on July 31 at 4:15 p.m. ET, presented by Chairman & CEO Scott Pomeroy, hosted by RedChip Companies.

AQMS - Hosting a facility tour as part of NAATBatt's Eighth Annual Workshop on Lithium Battery Recycling, showcasing its Innovation Center on July 31.

KNW - Reconvening its Special Meeting of Stockholders on July 31 at 1:30 p.m. PT to allow more time for shareholder votes on key proposals tied to a transformative financing deal.

● The company entered into a Securities Purchase Agreement with Goldeneye 1995 LLC involving a private placement valued at over $100 million.

● The deal includes 1,000 Bitcoin plus up to $15 million in cash, with a per-share purchase price of $0.335.

● Based on current BTC value (~$105,000), the investor could receive 350–357 million shares.

ASBP - Launching its BUZZ BOMB™ sublingual pre-workout supplement at FitCon (Salt Lake City, Aug 1–2) and FitExpo (Anaheim, Aug 2–3), two premier fitness industry expos.

RSLS - Hosting the inaugural Lap-Band® Surgeon Summit from August 1–3 in Nashville, TN, led by Dr. Christine Ren-Fielding of NYU. The summit includes presentations from top bariatric surgeons and program directors.

IMDX - Presenting extended clinical data on transplant diagnostics at the ESOT Congress (June 29–July 2, London), following initial findings from ERA 2025.

NKTX - Participating in the H.C. Wainwright "HCW@Home" Virtual Investor Series on July 30.

VIOT - Declaring a special dividend of US$0.0880 per ADS (approx. US$6 million total payout). Record date is July 31, with payment expected around August 21.

NIXX - Signed a non-binding letter of intent to acquire ReFuel Mobile, a Canadian mobile fueling company. Deal includes full retention of staff and is expected to close by August 1, pending due diligence.

MDIA - Announced the return of Objetivo Fama, premiering on EstrellaTV August 2, 2025. New season includes 14 weeks of primetime episodes airing Saturdays and Wednesdays.

--

Disclaimer: All content provided by BigTimePennys Report is for informational purposes only. The information provided should not be considered as a substitute for professional advice, analysis, or guidance. Any investment decisions made based on the information provided are solely at the user's own risk. BigTimePennys Report are not liable for any losses or damages incurred as a result of using this information. BigTimePenny is not operated by a licensed broker, a dealer, or a registered investment adviser. The Securities Litigation Reform Act of 1995 provides safe harbor protection for forward-looking statements made by companies or individuals. It should be noted that any forward-looking statements made by BigTimePennys Report, its authors, are not guarantees of future performance or results. These statements are subject to risks, uncertainties, and assumptions that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. The content provided by BigTimePennys Report does not constitute an endorsement, recommendation, or solicitation to buy, sell, or hold any securities or investment products. BigTimePennys Report, its authors, do not endorse or recommend any specific investment strategies, securities, or companies. It is crucial to conduct thorough research and seek advice from a qualified professional before making any investment decisions. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. The user assumes full responsibility for the use of the information provided by BigTimePennys Report. BigTimePennys Report, its authors, disclaim any liability for any direct, indirect, or consequential damages arising from the use or reliance on the information provided. Users should exercise their own judgment and discretion when interpreting and utilizing the information provided. Please note that the content provided by BigTimePennys Report is based on available information and sources believed to be reliable. However, market conditions and regulations may change over time, and there may be inaccuracies or errors in the information provided. It is recommended to verify the information with current and reliable sources before making any investment decisions. Investing in micro-cap companies is highly speculative and carries an extremely high degree of risk. BigTimePenny is not a fiduciary by virtue of any person's use of or access to this content. We were NOT compensated for this article.